The elevated expression of MECP2, MBD2, TET3, TET2, and DNMT3A in macrophages, particularly in omental tissue, supports the hypothesis of epigenetic reprogramming contributing to the development of insulin resistance, as macrophage-driven inflammation is a hallmark of IR-associated adipose remodeling. The gene discussed is MBD2; the disease is Insulin resistance.